Showing 1 - 3 of 3 Amyotrophic Lateral Sclerosis (ALS)

Status: Enrolling

Investigator: Ericka Greene

Study Coordinator: Rachel Applegate

Phone: 713.441.9120

This study is only eligible for ALS patients who are positive for the SOD1 gene. It is a double blind, placebo controlled infusion of an antisense oligonucleotide, administered intrathecally 8 times over the course of the 28 week study. There is ... Read more >

Status: Enrolling

Investigator: Stanley Appel

Study Coordinator: Sharon Halton

Phone: 713.441.3420

The purpose of the this study to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progre ... Read more >

Status: Active

Investigator: Jason Thonhoff

Study Coordinator: Sharon Halton

Phone: 713.441.3420

This study is a randomized, placebo-controlled, phase 2a trial to study the biological activity, safety, and tolerability of regulatory T Lymphocytes (Tregs) taken and expanded outside of the body and returned back to the same person whose Treg ... Read more >

Live Chat Available